• Dasa will hold an extraordinary shareholder meeting in digital format on Aug. 3, 2026.
• Shareholders will vote on the proposed merger of Patologia Clínica Dr. Geraldo Lustosa Cabral into Dasa.
• The meeting will also consider appointing Apsis Consultoria e Avaliações as independent appraiser.
• Items include reviewing the appraisal report, voting on the transaction, and authorizing management to execute the steps required to complete it.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. DASA - Diagnósticos da América SA published the original content used to generate this news brief on July 13, 2026, and is solely responsible for the information contained therein.